BackAssembly Biosciences Overview
Assembly Biosciences Inc

Assembly Biosciences Target Price

See Assembly Biosciences's analyst price targets ($52) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$21.12

Average Target Price

$51.67144.6% upside

3 analysts in the last 4 months

High: $53 | Low: $50

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-01Mizuho SecuritiesSalim Syed$53150.9% upsideOpen
2026-09-01UBSAshwani Verma$52146.2% upsideOpen
2026-08-18H.C. WainwrightPatrick Trucchio$50136.7% upsideOpen
2026-06-15Mizuho Securities$45113.1% upsideOpen
2025-11-20Mizuho SecuritiesSalim Syed$4089.4% upsideOpen
2025-09-24JMP SecuritiesRoy Buchanan$3879.9% upsideOpen
2024-09-24Mizuho SecuritiesSalim Syed$3670.5% upsideOpen
2024-09-20JefferiesDennis Ding$3565.7% upsideOpen

Assembly Biosciences (ASMB) FAQ

As of the most recent data, ASMB shows a target price of $52. Scroll down for historical charts and peer comparison views.

If Assembly Biosciences moved to the average analyst target of $52, shares would be roughly 144.6% higher than $21.12. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Assembly Biosciences's earnings trajectory.

Besides this target price page, Stockcircle has Assembly Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $52) with ownership activity and broader fundamentals.

Assembly Biosciences's target price is $52; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.